|Date:||November 14, 2019 | 8:00 am – 5:00 pm
November 15, 2019 | 8:30 am – 3:30 pm
|Location:||Eilan Hotel & Spa
18603 La Cantera Terrace
San Antonio, TX 78256
» Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″
Dr. Bäumler’s research involves enteric pathogens, the host, and its gut microbiota. His lab has a histiory of pioneering new models and approaches to address key questions about the pathogenesis of gastroenteritis. Their research also involves typhoid fever pathogenesis and interactions between Salmonella, the host, and its microbiota. More recenly, the lab has become interested in mechanisms that lower colonization resistance against Enterobacteriaceae.
Dr. Dye oversees the execution of research programs with the aim to counteract the Ebola virus and other high-risk pathogens. He is involved in developing vaccines and therapeutics for hemorrhagic fever viruses and guiding the team in completing basic science and applied research in support of Department of Defense and U.S. Government interests.
The goal of Dr. Rubin’s lab is to better understand the basic biology of Mycobacterium tuberculosis and to develop new therapeutic strategies. They study the fundamental cell biology of the organisms, investigate the interface between the host and pathogen, and try to change the process of antibiotic discovery using new approaches to finding antibacterial compounds and understanding their mechanisms of action. A variety of tools, many developed in the lab, are used to manipulate and study this pathogen.
Dr. Wilson has recently risen to prominence in the field of B cell biology and particularly in the study of antibody specificity. Using technology that he helped develop, his lab has become one of the worlds best at generating human monoclonal antibody proteins. By focusing on antibody responses, Dr. Wilson has made a number of notable discoveries in recent years. In addition to further understanding how our bodies fight influenza, the protective antibodies against influenza that his lab has generated are being developed as new therapeutics and diagnostics.